One checkpoint may hide another: inhibiting the TGFβ signaling pathway enhances immune checkpoint blockade

Tumors employ several mechanisms to evade recognition by the immune system. Among these are epigenetic changes such as loss of the antigen presenting machinery (e.g., HLA-A,B,C) that cause tumors to become invisible to the immune system.